Skip to content
Menu
  • About Us
  • Our Team
  • Partnerships
  • Pipeline
  • Discovery
  • Contact
Contact Us
  • About
  • Contact
  • Discovery
  • Home Page
  • Our Team
  • Partnerships
  • Pipeline
  • Privacy Policy
  • Terms of Use

    • VM-PSY-001

    • Post author:Manos Kavvousanos
    • Post published:December 8, 2025
    • Post category:

    An investigational oral therapy being developed for individuals with alcohol use disorder.

    Continue ReadingVM-PSY-001
    • Go to the previous page
    • 1
    • 2

    Archives

    • December 2025

    Categories

    • Uncategorized

    A clinical-stage pharmaceutical company accelerating drug development through AI, strategic partnerships, and a diverse portfolio of high-impact therapies.

     

    Quick Links

    • About Us
    • Our Team
    • Partnerships
    • Pipeline
    • Discovery
    • Contact
    • Privacy Policy
    • Terms of Use
    Contact
    • Phoenix | New York | Basel | Bogotá | Riyadh
    • info@vivamed.com
    • LinkedIn

    General Disclaimer – VivaMed.com is for general informational purposes only and is not medical, legal, tax, or investment advice.  Please do not submit patient-identifiable or other sensitive health information through this website. 

    • VivaMed BioPharma © 2025. All rights reserved.